Equillium Inc [NASDAQ: EQ] gained 8.04% on the last trading session, reaching $0.34 price per share at the time.
Equillium Inc represents 35.72 million in outstanding shares, while the company has a total market value of $12.04 million with the latest information. EQ stock price has been found in the range of $0.2924 to $0.484.
If compared to the average trading volume of 650.13K shares, EQ reached a trading volume of 6144979 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Equillium Inc [EQ]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EQ shares is $1.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EQ stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Equillium Inc shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on March 28, 2025. While these analysts kept the previous recommendation, Stifel raised their target price to Buy. The new note on the price target was released on October 29, 2021, representing the official price target for Equillium Inc stock. Previously, the target price had yet another raise to $14, while Cantor Fitzgerald analysts kept a Overweight rating on EQ stock. On July 14, 2020, analysts increased their price target for EQ shares from 14 to 24.
The Price to Book ratio for the last quarter was 1.14, with the Price to Cash per share for the same quarter was set at 0.41.
Trading performance analysis for EQ stock
Equillium Inc [EQ] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.02. With this latest performance, EQ shares dropped by -11.29% in over the last four-week period, additionally sinking by -56.56% over the last 6 months – not to mention a drop of -54.95% in the past year of trading.
Equillium Inc [EQ]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Equillium Inc [EQ] shares currently have an operating margin of -47.18% and a Gross Margin at 99.55%. Equillium Inc’s Net Margin is presently recorded at -46.00%.
Return on Equity for this stock declined to -46.37%, with Return on Assets sitting at -46.37%.
An analysis of Institutional ownership at Equillium Inc [EQ]
There are presently around $19.14%, or 29.86% of EQ stock, in the hands of institutional investors. The top three institutional holders of EQ stocks are: DECHENG CAPITAL LLC with ownership of 4.45 million shares, which is approximately 12.6148%. TAKEDA PHARMACEUTICAL CO LTD, holding 1.82 million shares of the stock with an approximate value of $$1.26 million in EQ stocks shares; and TAKEDA PHARMACEUTICAL CO LTD, currently with $$0.58 million in EQ stock with ownership which is approximately 2.3882%.
